Multibagger pharma penny stock under Rs 5 jumps after entering into a Supper stockist agreement with Amneal Healthcare Private Limited
The company has a market cap of Rs 223 crore and the stock gave multibagger returns of over 100 per cent from its 52-week low of Rs 1.92 per share.
On Tuesday, shares of Genpharmasec Ltd gained 2.29 per cent to Rs 4.02 per share from its previous closing of Rs 3.93 per share with an intraday high of Rs 4.32 per share and an intraday low of Rs 3.54 per share. The shares of the company saw a spurt in volume by more than 4.25 times on BSE.
Genpharmasec Limited has achieved a significant milestone by entering into a Supper Stockist agreement with Amneal Healthcare Private Limited. This agreement appoints Genpharmasec as a non-exclusive Supper Stockist within a specific territory, allowing them to sell products manufactured by Amneal Healthcare, its third-party contact manufacturers, or third-party licensors to wholesale and retail pharmacists. As part of this agreement, Amneal Healthcare has committed to providing Genpharmasec with a minimum annual sales commitment of approximately INR 60 Crores for the period from January 1, 2025, to December 31, 2025.
Commenting on the development Mr. Rajesh Sadhwani, Promoter and Director of Genpharmasec Limited said: We are excited to enter into a Super Stockist Agreement with AHPL, a highly respected name in the healthcare industry. This agreement represents a key step forward in our commitment to expanding our presence in the market and strengthening our distribution capabilities. By working with AHPL, we will be able to offer an even wider range of high-quality healthcare products to our customers, ensuring greater accessibility and service excellence. This collaboration is not only a testament to the trust and synergy between our organizations but also lays the foundation for sustained growth and mutual success in the years to come. We look forward to a fruitful partnership with AHPL and are confident that it will bring significant value to both parties.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
Incorporated in 1992, Genpharmasec Ltd. initially focused on manufacturing and trading organic and inorganic chemicals, dyes, and pigments. Since 2018, the company has pivoted its business model to buying, selling, and distributing a wide range of pharmaceutical, medicinal, and medicated preparations.
Genpharmasec Ltd. has established a strategic partnership with Abbott Point of Care Corporation INC, USA. This collaboration empowers the company to distribute innovative diagnostic equipment, specifically the i-STAT 1 Analyzer. This handheld blood analyzer is a crucial tool in intensive care units (ICUs) and critical care units (CCUs) of hospitals, providing rapid test results. By supplying i-STAT 1 Analyzers to distributors nationwide, Genpharmasec Ltd. contributes to enhancing healthcare delivery in both government and private hospitals across the country.
The company has a market cap of Rs 223 crore and the stock gave multibagger returns of over 100 per cent from its 52-week low of Rs 1.92 per share. Investors should keep an eye on this pharma penny stock.
Disclaimer: The article is for informational purposes only and not investment advice.